acetylcarnitine has been researched along with Alloxan Diabetes in 28 studies
Acetylcarnitine: An acetic acid ester of CARNITINE that facilitates movement of ACETYL COA into the matrices of mammalian MITOCHONDRIA during the oxidation of FATTY ACIDS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Animals with 4 weeks of hyperglycemia and reduced NCV treated with an aldose reductase inhibitor (sorbinil) or a short-chain acyl-carnitine (acetyl-L-carnitine [ALC]) daily for 16 weeks showed an improvement in NCV." | 3.69 | The effects of acetyl-L-carnitine and sorbinil on peripheral nerve structure, chemistry, and function in experimental diabetes. ( Carver, J; Korthals, JK; Lowitt, S; Malone, JI; Miranda, C; Salem, AF, 1996) |
| "Flurbiprofen treatment of ND rats replicated many of the biochemical and physiological abnormalities of EDN, i." | 1.31 | Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration. ( Greene, DA; Larkin, D; Li, F; Marinescu, V; Pop-Busui, R; Stevens, MJ; Sullivan, K; Van Huysen, C, 2002) |
| "Sorbinil treatment was associated with normalized sciatic nerve sorbitol and myo-inositol; ALC treatment did not reduce the elevated sorbitol levels, but sciatic nerve myo-inositol content was no different from nondiabetic levels." | 1.29 | Acetyl-L-carnitine corrects the altered peripheral nerve function of experimental diabetes. ( Benford, S; Korthals, J; Lowitt, S; Malone, JI; Salem, AF, 1995) |
| "Treatment with sorbinil was associated with normalization of the tissue sorbitol (0." | 1.28 | Altered neuroexcitability in experimental diabetic neuropathy: effect of acetyl-L-carnitine. ( Corsico, N; Lowitt, S; Malone, JI; Orfalian, Z, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (7.14) | 18.7374 |
| 1990's | 15 (53.57) | 18.2507 |
| 2000's | 8 (28.57) | 29.6817 |
| 2010's | 2 (7.14) | 24.3611 |
| 2020's | 1 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Yao, H | 1 |
| Wang, Y | 1 |
| Zhang, X | 1 |
| Li, P | 1 |
| Shang, L | 1 |
| Chen, X | 1 |
| Zeng, J | 1 |
| Wang, CH | 1 |
| Wang, SS | 1 |
| Ko, WJ | 1 |
| Chen, YS | 1 |
| Chang, CY | 1 |
| Chang, RW | 1 |
| Chang, KC | 3 |
| Tseng, CD | 1 |
| Lu, SC | 1 |
| Liang, JT | 1 |
| Wu, MS | 1 |
| Tsai, MS | 1 |
| Hsu, KL | 1 |
| Pop-Busui, R | 1 |
| Marinescu, V | 1 |
| Van Huysen, C | 1 |
| Li, F | 1 |
| Sullivan, K | 1 |
| Greene, DA | 2 |
| Larkin, D | 1 |
| Stevens, MJ | 2 |
| PEARSON, DJ | 1 |
| TUBBS, PK | 1 |
| Defani, MA | 4 |
| Zanoni, JN | 2 |
| Natali, MR | 2 |
| Bazotte, RB | 2 |
| de Miranda-Neto, MH | 1 |
| Fregonesi, CE | 3 |
| Molinari, SL | 1 |
| Alves, AM | 2 |
| de Miranda Neto, MH | 3 |
| Pereira, A | 1 |
| Alves, EP | 1 |
| Stabille, SR | 1 |
| Evangelista, CC | 1 |
| Dos Santos, CA | 1 |
| Cresto, JC | 1 |
| Fabiano de Bruno, LE | 1 |
| Cao, GF | 1 |
| Pastorale, CF | 1 |
| Confalonieri, N | 1 |
| del Carmen Camberos, M | 1 |
| Basabe, JC | 1 |
| Ohsawa, M | 1 |
| Miyata, S | 1 |
| Carlsson, A | 1 |
| Kamei, J | 1 |
| Cotter, MA | 1 |
| Cameron, NE | 1 |
| Keegan, A | 1 |
| Dines, KC | 1 |
| Lowitt, S | 4 |
| Malone, JI | 4 |
| Salem, AF | 2 |
| Korthals, J | 1 |
| Benford, S | 1 |
| Ido, Y | 1 |
| McHowat, J | 1 |
| Arrigoni-Martelli, E | 1 |
| Orfalian, Z | 3 |
| Kilo, C | 1 |
| Corr, PB | 1 |
| Williamson, JR | 1 |
| Salem, A | 1 |
| Kozak, WM | 1 |
| Marzo, A | 1 |
| Corsico, N | 3 |
| Cardace, G | 1 |
| Morabito, E | 2 |
| Serafini, S | 1 |
| Martelli, EA | 1 |
| Lattimer, SA | 1 |
| Feldman, EL | 1 |
| Helton, ED | 1 |
| Millington, DS | 1 |
| Sima, AA | 1 |
| Miranda, C | 1 |
| Korthals, JK | 1 |
| Carver, J | 1 |
| Abdel-aleem, S | 1 |
| Karim, AM | 1 |
| Zarouk, WA | 1 |
| Taylor, DA | 1 |
| el-Awady, MK | 1 |
| Lowe, JE | 1 |
| Nakamura, J | 1 |
| Koh, N | 1 |
| Sakakibara, F | 1 |
| Hamada, Y | 1 |
| Hara, T | 1 |
| Sasaki, H | 1 |
| Chaya, S | 1 |
| Komori, T | 1 |
| Nakashima, E | 1 |
| Naruse, K | 1 |
| Kato, K | 1 |
| Takeuchi, N | 1 |
| Kasuya, Y | 1 |
| Hotta, N | 1 |
| Kano, M | 1 |
| Kawakami, T | 1 |
| Hori, H | 1 |
| Hashimoto, Y | 1 |
| Tao, Y | 1 |
| Ishikawa, Y | 1 |
| Takenaka, T | 1 |
| Lo Giudice, P | 1 |
| Careddu, A | 1 |
| Magni, G | 1 |
| Quagliata, T | 1 |
| Pacifici, L | 2 |
| Carminati, P | 1 |
| Gorio, A | 3 |
| Di Giulio, AM | 2 |
| Tenconi, B | 1 |
| Donadoni, L | 1 |
| Germani, E | 1 |
| Bertelli, A | 2 |
| Mantegazza, P | 2 |
| Maccari, F | 2 |
| Ramacci, MT | 3 |
| Ferraris, L | 1 |
| Bellucci, A | 1 |
| Piovesan, P | 1 |
| Hekimian, G | 1 |
| Feuvray, D | 1 |
28 other studies available for acetylcarnitine and Alloxan Diabetes
| Article | Year |
|---|---|
Targeting peroxisomal fatty acid oxidation improves hepatic steatosis and insulin resistance in obese mice.
Topics: Acetyl Coenzyme A; Acetylcarnitine; Animals; Diabetes Mellitus, Experimental; Fatty Acids; Fatty Liv | 2023 |
Acetyl-l-carnitine and oxfenicine on cardiac pumping mechanics in streptozotocin-induced diabetes in male Wistar rats.
Topics: Acetylcarnitine; Animals; Antioxidants; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Glycine; | 2013 |
Effects of acetyl-L-carnitine and oxfenicine on aorta stiffness in diabetic rats.
Topics: Acetylcarnitine; Analysis of Variance; Animals; Aorta; Carnitine O-Palmitoyltransferase; Diabetes Me | 2010 |
Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration.
Topics: Acetylcarnitine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Cyclooxygenase | 2002 |
ACETYL-CARNITINE IN HEART AND LIVER.
Topics: Acetates; Acetylcarnitine; Acyltransferases; Animals; Coenzyme A; Diabetes Mellitus, Experimental; G | 1964 |
Effect of acetyl-L-carnitine on VIP-ergic neurons in the jejunum submucous plexus of diabetic rats.
Topics: Acetylcarnitine; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Die | 2003 |
Morphoquantitative aspects of nitrergic myoenteric neurons from the stomach of diabetic rats supplemented with acetyl-L-carnitine.
Topics: Acetylcarnitine; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dietary Supplements; Male; | 2005 |
Morphometric and quantitative evaluation of the NADH-diaphorase positive myenteric neurons of the jejunum of streptozotocin-diabetic rats supplemented with acetyl-L-carnitine.
Topics: Acetylcarnitine; Animals; Blood Glucose; Cell Proliferation; Diabetes Mellitus, Experimental; Histoc | 2005 |
Morphoquantitative aspects of NADH-diaphorase myenteric neurons in the ileum of diabetic rats treated with acetyl-L-carnitine.
Topics: Acetylcarnitine; Animals; Diabetes Mellitus, Experimental; Dihydrolipoamide Dehydrogenase; Histocyto | 2006 |
The association of acetyl-l-carnitine and nicotinamide remits the experimental diabetes in mice by multiple low-dose streptozotocin.
Topics: Acetylcarnitine; Animals; Blood Glucose; Body Weight; Cells, Cultured; Diabetes Mellitus, Experiment | 2006 |
Preventive effect of acetyl-L-carnitine on the thermal hypoalgesia in streptozotocin-induced diabetic mice.
Topics: Acetylcarnitine; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Male; Mice; Mice, | 2008 |
Effects of acetyl- and proprionyl-L-carnitine on peripheral nerve function and vascular supply in experimental diabetes.
Topics: Acetylcarnitine; Action Potentials; Animals; Blood Flow Velocity; Blood Glucose; Body Weight; Carnit | 1995 |
Acetyl-L-carnitine corrects the altered peripheral nerve function of experimental diabetes.
Topics: Acetylcarnitine; Aldehyde Reductase; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies | 1995 |
Neural dysfunction and metabolic imbalances in diabetic rats. Prevention by acetyl-L-carnitine.
Topics: Acetylcarnitine; Animals; Ca(2+) Mg(2+)-ATPase; Carnitine; Diabetes Mellitus, Experimental; Diabetic | 1994 |
Acetyl-L-carnitine corrects electroretinographic deficits in experimental diabetes.
Topics: Acetylcarnitine; Aldehyde Reductase; Analysis of Variance; Animals; Diabetes Mellitus, Experimental; | 1993 |
Effect of acetyl-L-carnitine treatment on the levels of levocarnitine and its derivatives in streptozotocin-diabetic rats.
Topics: Acetylcarnitine; Animals; Behavior, Animal; Blood Glucose; Carnitine; Diabetes Mellitus, Experimenta | 1993 |
Acetyl-L-carnitine effect on nerve conduction velocity in streptozotocin-diabetic rats.
Topics: Acetylcarnitine; Animals; Diabetes Mellitus, Experimental; Male; Neural Conduction; Rats | 1993 |
Acetyl-L-carnitine deficiency as a cause of altered nerve myo-inositol content, Na,K-ATPase activity, and motor conduction velocity in the streptozotocin-diabetic rat.
Topics: Acetylcarnitine; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Rela | 1996 |
The effects of acetyl-L-carnitine and sorbinil on peripheral nerve structure, chemistry, and function in experimental diabetes.
Topics: Acetylcarnitine; Aldehyde Reductase; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies | 1996 |
Reduced effects of L-carnitine on glucose and fatty acid metabolism in myocytes isolated from diabetic rats.
Topics: Acetyl Coenzyme A; Acetylcarnitine; Animals; Carbon Radioisotopes; Carnitine; Citric Acid Cycle; Dia | 1997 |
Polyol pathway hyperactivity is closely related to carnitine deficiency in the pathogenesis of diabetic neuropathy of streptozotocin-diabetic rats.
Topics: Acetylcarnitine; Aldehyde Reductase; Animals; Body Weight; Carnitine; Diabetes Mellitus, Experimenta | 1998 |
Effects of ALCAR on the fast axoplasmic transport in cultured sensory neurons of streptozotocin-induced diabetic rats.
Topics: Acetylcarnitine; Afferent Pathways; Animals; Axonal Transport; Blood Glucose; Body Weight; Cells, Cu | 1999 |
Autonomic neuropathy in streptozotocin diabetic rats: effect of acetyl-L-carnitine.
Topics: Acetylcarnitine; Animals; Autonomic Nervous System Diseases; Blood Glucose; Body Weight; Diabetes Me | 2002 |
Peptide alterations in autonomic diabetic neuropathy prevented by acetyl-L-carnitine.
Topics: Acetylcarnitine; Animals; Autonomic Nervous System Diseases; Diabetes Mellitus, Experimental; Diabet | 1992 |
Acetyl-L-carnitine prevents substance P loss in the sciatic nerve and lumbar spinal cord of diabetic animals.
Topics: Acetylcarnitine; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Lumbar Vertebrae; | 1992 |
Counteraction on experimentally induced diabetic neuropathy by levocarnitine acetyl.
Topics: Acetylcarnitine; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Male; Motor Activi | 1992 |
Altered neuroexcitability in experimental diabetic neuropathy: effect of acetyl-L-carnitine.
Topics: Acetylcarnitine; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Imidazoles; Imidaz | 1992 |
Reduction of ischemia-induced acyl carnitine accumulation by TDGA and its influence on lactate dehydrogenase release in diabetic rat hearts.
Topics: Acetylcarnitine; Adenosine Triphosphate; Animals; Carnitine; Coronary Disease; Diabetes Mellitus, Ex | 1986 |